Hyaluronic acid family in bladder cancer: potential prognostic biomarkers and therapeutic targets

BACKGROUND: Molecular markers of clinical outcome may aid in designing targeted treatments for bladder cancer. However, only a few bladder cancer biomarkers have been examined as therapeutic targets. METHODS: Data from The Cancer Genome Atlas (TCGA) and bladder specimens were evaluated to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: Morera, Daley S, Hennig, Martin S, Talukder, Asif, Lokeshwar, Soum D, Wang, Jiaojiao, Garcia-Roig, Michael, Ortiz, Nicolas, Yates, Travis J, Lopez, Luis E, Kallifatidis, Georgios, Kramer, Mario W, Jordan, Andre R, Merseburger, Axel S, Manoharan, Murugesan, Soloway, Mark S, Terris, Martha K, Lokeshwar, Vinata B
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680466/
https://www.ncbi.nlm.nih.gov/pubmed/28972965
http://dx.doi.org/10.1038/bjc.2017.318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5680466/
https://www.ncbi.nlm.nih.gov/pubmed/28972965
http://dx.doi.org/10.1038/bjc.2017.318

Ejemplares similares